11-13 November 2025
Congress Center BaselBasel, SwitzerlandDr. Sally Jiao, PhDAdvisor - Engineering at Eli Lilly & CompanySpeaker
Profile
Dr. Sally Jiao joined the Synthetic Molecule Design and Development department at Eli Lilly in Feb 2024 and works on upstream process development, PAT, and modeling for oligonucleotide assets, focusing on the fluidized bed reactor (FBR) technology. Sally holds a PhD in chemical engineering from the University of California, Santa Barbara, and a BS in chemical engineering from Princeton University. Sally has received a Lilly Innovator Award for her work on PAT.
Agenda Sessions
Fluidized Bed Reactor Strategy to Solid Phase Synthesis from Regulatory Perspective
, 09:05View Session